Baystar details PECE holdings as CEO Zheng controls 10% stake
Rhea-AI Filing Summary
Peace Acquisition Corp. insider Baystar Holding Group Limited has filed an initial Form 3 showing a significant indirect stake. Baystar reports beneficial ownership of 1,743,500 ordinary shares and derivative positions in warrants and rights linked to additional ordinary shares.
The filing notes that Baystar has irrevocably agreed to purchase IPO units containing shares, warrants and rights, with 201,000 shares subject to forfeiture if underwriters do not exercise their over-allotment option and a further 17,357 shares only issuable if the over-allotment is fully exercised. CEO Fangping Zheng, a director and ten percent owner, is disclosed as the sole director and shareholder of Baystar.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Rights | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (6)
- F1. Includes (i) 202,500 shares contained within units that Baystar Holding Group Limited has irrevocably agreed to purchase at the closing of the Issuer's initial public offering (the "IPO") and (ii) 201,000 shares subject to forfeiture in the event the underwriters of the IPO do not exercise their overallotment option. Does not include an additional 17,357 shares contained within units that Baystar Holding Group Limited has irrevocably agreed to purchase in connection with the IPO if and only if the underwriters of the IPO fully exercise their over-allotment option.
- F2. Fangping Zheng is the sole director and shareholder of Baystar Holding Group Limited
- F3. Represents 202,500 rights contained within units that Baystar Holding Group Limited has irrevocably agreed to purchase at the closing of the IPO. Does not include an additional 17,357 rights contained within units that Baystar Holding Group Limited has irrevocably agreed to purchase in connection with the IPO if and only if the underwriters of the IPO fully exercise their over-allotment option. Each right will convert automatically into 1/5 of one ordinary share at the closing of an initial business combination by the Issuer. The rights do not have an expiration date.
- F4. Each warrant will become exercisable at the later of 12 months from the closing of the IPO and 30 days after the completion of the Issuer's initial business combination.
- F5. Each warrant will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or the Issuer's liquidation.
- F6. Does not include up to an additional 17,357 ordinary shares underlying warrants contained within units that the reporting person has irrevocably agreed to purchase in connection with the IPO if and only if the underwriters of the IPO fully exercise their over-allotment option.
Key Figures
Key Terms
over-allotment option financial
initial public offering financial
initial business combination financial
rights financial
warrants financial
AI-generated analysis. How Rhea-AI works. Not financial advice.